Mark Nehler
Concepts (392)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ischemia | 29 | 2022 | 362 | 4.260 |
Why?
| Peripheral Arterial Disease | 27 | 2023 | 380 | 4.040 |
Why?
| Internship and Residency | 15 | 2024 | 926 | 2.360 |
Why?
| Lower Extremity | 17 | 2022 | 335 | 2.130 |
Why?
| Vascular Surgical Procedures | 21 | 2023 | 259 | 1.980 |
Why?
| General Surgery | 8 | 2024 | 127 | 1.860 |
Why?
| Endovascular Procedures | 10 | 2023 | 269 | 1.550 |
Why?
| Leg | 14 | 2007 | 225 | 1.540 |
Why?
| Rivaroxaban | 15 | 2022 | 211 | 1.440 |
Why?
| Platelet Aggregation Inhibitors | 15 | 2022 | 401 | 1.440 |
Why?
| Peripheral Vascular Diseases | 12 | 2022 | 97 | 1.380 |
Why?
| Blood Vessel Prosthesis Implantation | 6 | 2023 | 181 | 1.060 |
Why?
| Limb Salvage | 9 | 2021 | 52 | 0.990 |
Why?
| Aspirin | 14 | 2022 | 324 | 0.970 |
Why?
| Surgeons | 4 | 2021 | 239 | 0.930 |
Why?
| Femoral Artery | 10 | 2023 | 167 | 0.850 |
Why?
| Arterial Occlusive Diseases | 7 | 2008 | 74 | 0.820 |
Why?
| Education, Medical, Graduate | 5 | 2024 | 368 | 0.810 |
Why?
| Treatment Outcome | 43 | 2023 | 9088 | 0.780 |
Why?
| Aortic Aneurysm, Abdominal | 3 | 2017 | 113 | 0.730 |
Why?
| Risk Factors | 33 | 2023 | 8632 | 0.700 |
Why?
| Popliteal Artery | 7 | 2023 | 57 | 0.690 |
Why?
| Intermittent Claudication | 12 | 2022 | 108 | 0.690 |
Why?
| Puerperal Disorders | 1 | 2020 | 30 | 0.680 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 64 | 0.680 |
Why?
| Career Choice | 3 | 2020 | 177 | 0.670 |
Why?
| Factor Xa Inhibitors | 7 | 2022 | 138 | 0.660 |
Why?
| Personnel Selection | 3 | 2018 | 62 | 0.650 |
Why?
| Vascular System Injuries | 4 | 2021 | 66 | 0.610 |
Why?
| Vascular Patency | 13 | 2023 | 97 | 0.600 |
Why?
| Time Factors | 21 | 2022 | 6116 | 0.600 |
Why?
| Aged | 45 | 2023 | 19074 | 0.590 |
Why?
| Postoperative Complications | 11 | 2022 | 2128 | 0.580 |
Why?
| Humans | 106 | 2024 | 114696 | 0.570 |
Why?
| Risk Assessment | 15 | 2021 | 2968 | 0.550 |
Why?
| Male | 66 | 2023 | 55604 | 0.550 |
Why?
| Clinical Competence | 4 | 2022 | 893 | 0.540 |
Why?
| Female | 63 | 2023 | 59518 | 0.530 |
Why?
| Quality Indicators, Health Care | 3 | 2016 | 287 | 0.520 |
Why?
| Elective Surgical Procedures | 2 | 2017 | 151 | 0.520 |
Why?
| Mentors | 2 | 2020 | 156 | 0.510 |
Why?
| Venous Thromboembolism | 3 | 2023 | 231 | 0.490 |
Why?
| Middle Aged | 45 | 2023 | 26737 | 0.480 |
Why?
| Thrombosis | 4 | 2023 | 298 | 0.480 |
Why?
| Arteriovenous Shunt, Surgical | 2 | 2011 | 15 | 0.450 |
Why?
| Retrospective Studies | 27 | 2024 | 12554 | 0.450 |
Why?
| Renal Dialysis | 3 | 2013 | 374 | 0.430 |
Why?
| Upper Extremity | 2 | 2011 | 84 | 0.420 |
Why?
| Angioplasty, Balloon | 3 | 2023 | 88 | 0.420 |
Why?
| Aged, 80 and over | 20 | 2017 | 6347 | 0.410 |
Why?
| Paclitaxel | 3 | 2021 | 190 | 0.400 |
Why?
| Kidney Failure, Chronic | 4 | 2013 | 489 | 0.380 |
Why?
| Quality of Life | 6 | 2022 | 2353 | 0.360 |
Why?
| Patient Care Management | 1 | 2011 | 53 | 0.360 |
Why?
| Activities of Daily Living | 4 | 2006 | 349 | 0.350 |
Why?
| Incidence | 8 | 2021 | 2313 | 0.350 |
Why?
| Alprostadil | 2 | 2007 | 32 | 0.350 |
Why?
| Medicaid | 1 | 2014 | 407 | 0.340 |
Why?
| Wound Healing | 5 | 2009 | 258 | 0.330 |
Why?
| Patient Readmission | 5 | 2023 | 610 | 0.330 |
Why?
| Medicare | 1 | 2014 | 665 | 0.320 |
Why?
| Continuity of Patient Care | 1 | 2011 | 253 | 0.310 |
Why?
| Adult | 30 | 2023 | 30552 | 0.310 |
Why?
| Brain Ischemia | 2 | 2022 | 299 | 0.310 |
Why?
| Kidney Diseases | 2 | 2011 | 350 | 0.300 |
Why?
| Drug-Eluting Stents | 2 | 2021 | 62 | 0.300 |
Why?
| Students, Medical | 2 | 2023 | 263 | 0.300 |
Why?
| Comorbidity | 7 | 2017 | 1448 | 0.290 |
Why?
| Critical Illness | 6 | 2020 | 646 | 0.290 |
Why?
| Neoplasms | 1 | 2021 | 2097 | 0.290 |
Why?
| Decision Support Techniques | 2 | 2021 | 355 | 0.290 |
Why?
| United States | 15 | 2024 | 12185 | 0.280 |
Why?
| Stroke | 3 | 2022 | 1022 | 0.280 |
Why?
| Software | 1 | 2011 | 530 | 0.280 |
Why?
| Ribs | 2 | 2016 | 29 | 0.280 |
Why?
| Computer Simulation | 1 | 2011 | 873 | 0.280 |
Why?
| Myocardial Infarction | 3 | 2022 | 927 | 0.280 |
Why?
| Prodrugs | 1 | 2007 | 42 | 0.270 |
Why?
| Coronary Artery Disease | 3 | 2020 | 607 | 0.270 |
Why?
| Surveys and Questionnaires | 9 | 2022 | 4623 | 0.260 |
Why?
| Atherosclerosis | 2 | 2020 | 341 | 0.260 |
Why?
| Drug Therapy, Combination | 7 | 2022 | 951 | 0.260 |
Why?
| Thoracic Outlet Syndrome | 2 | 2016 | 12 | 0.260 |
Why?
| Hemorrhage | 7 | 2023 | 620 | 0.250 |
Why?
| Catheterization, Peripheral | 2 | 2009 | 101 | 0.250 |
Why?
| Reoperation | 10 | 2014 | 514 | 0.240 |
Why?
| Femoral Vein | 3 | 2008 | 28 | 0.240 |
Why?
| Graft Occlusion, Vascular | 3 | 2011 | 35 | 0.240 |
Why?
| Cardiovascular Surgical Procedures | 2 | 2001 | 29 | 0.240 |
Why?
| Iliac Aneurysm | 2 | 2022 | 17 | 0.230 |
Why?
| Carotid Stenosis | 2 | 1996 | 79 | 0.230 |
Why?
| Anticoagulants | 4 | 2023 | 550 | 0.230 |
Why?
| Fibrinolytic Agents | 3 | 2022 | 234 | 0.220 |
Why?
| Ultrasonography, Doppler | 2 | 2021 | 105 | 0.220 |
Why?
| Acute Disease | 4 | 2021 | 911 | 0.220 |
Why?
| Chi-Square Distribution | 3 | 2017 | 493 | 0.220 |
Why?
| Diabetes Complications | 3 | 2015 | 211 | 0.210 |
Why?
| Academic Medical Centers | 3 | 2017 | 411 | 0.210 |
Why?
| Cranial Nerve Injuries | 1 | 2023 | 5 | 0.210 |
Why?
| Carotid Body Tumor | 1 | 2023 | 5 | 0.210 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 2023 | 80 | 0.210 |
Why?
| Antifibrinolytic Agents | 1 | 2023 | 50 | 0.200 |
Why?
| Diabetic Foot | 2 | 2019 | 22 | 0.200 |
Why?
| Tibial Arteries | 4 | 2008 | 12 | 0.200 |
Why?
| Meditation | 1 | 2022 | 34 | 0.200 |
Why?
| Thrombolytic Therapy | 1 | 2003 | 117 | 0.200 |
Why?
| Quality Improvement | 2 | 2022 | 950 | 0.190 |
Why?
| Smoking Cessation | 2 | 2002 | 374 | 0.190 |
Why?
| Blood Vessel Prosthesis | 3 | 2022 | 112 | 0.190 |
Why?
| Heparin | 3 | 2023 | 224 | 0.190 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 2023 | 122 | 0.180 |
Why?
| Blood Coagulation Disorders | 1 | 2023 | 197 | 0.180 |
Why?
| Hemostatic Techniques | 1 | 2001 | 40 | 0.180 |
Why?
| Mentoring | 1 | 2022 | 100 | 0.180 |
Why?
| Specialties, Surgical | 2 | 2017 | 70 | 0.180 |
Why?
| Suture Techniques | 1 | 2001 | 115 | 0.180 |
Why?
| Double-Blind Method | 7 | 2020 | 1660 | 0.170 |
Why?
| Hospital Departments | 1 | 2020 | 8 | 0.170 |
Why?
| Aortic Diseases | 1 | 2001 | 106 | 0.170 |
Why?
| Blood Pressure Determination | 1 | 2021 | 122 | 0.170 |
Why?
| Databases, Factual | 4 | 2017 | 1125 | 0.170 |
Why?
| Hyperlipidemias | 1 | 2001 | 121 | 0.170 |
Why?
| Walking | 4 | 2022 | 422 | 0.170 |
Why?
| Multivariate Analysis | 4 | 2019 | 1430 | 0.170 |
Why?
| Logistic Models | 3 | 2017 | 1841 | 0.170 |
Why?
| Proportional Hazards Models | 3 | 2021 | 1075 | 0.170 |
Why?
| Forefoot, Human | 1 | 1999 | 6 | 0.170 |
Why?
| Clinical Clerkship | 1 | 2020 | 72 | 0.170 |
Why?
| Toes | 1 | 1999 | 26 | 0.170 |
Why?
| Counseling | 1 | 2002 | 342 | 0.170 |
Why?
| Aneurysm | 2 | 1997 | 29 | 0.160 |
Why?
| Self Concept | 1 | 2021 | 214 | 0.160 |
Why?
| Patient Selection | 4 | 2014 | 641 | 0.160 |
Why?
| Canagliflozin | 1 | 2019 | 8 | 0.160 |
Why?
| Chronic Disease | 6 | 2011 | 1578 | 0.160 |
Why?
| Exercise Therapy | 2 | 2001 | 352 | 0.160 |
Why?
| Drug Prescriptions | 1 | 2020 | 239 | 0.160 |
Why?
| Carotid Artery Diseases | 1 | 2019 | 57 | 0.160 |
Why?
| Iatrogenic Disease | 1 | 1998 | 49 | 0.150 |
Why?
| Follow-Up Studies | 9 | 2021 | 4411 | 0.150 |
Why?
| School Admission Criteria | 1 | 2018 | 20 | 0.150 |
Why?
| Extremities | 2 | 2009 | 113 | 0.150 |
Why?
| Odds Ratio | 3 | 2016 | 953 | 0.150 |
Why?
| Blood Vessels | 2 | 1998 | 180 | 0.150 |
Why?
| Cost of Illness | 1 | 2019 | 254 | 0.150 |
Why?
| Arm | 2 | 2004 | 104 | 0.150 |
Why?
| Diabetes Mellitus | 3 | 2021 | 900 | 0.150 |
Why?
| Arteriosclerosis | 1 | 1997 | 83 | 0.150 |
Why?
| Physician Executives | 1 | 2017 | 33 | 0.140 |
Why?
| Ultrasonography, Doppler, Duplex | 2 | 1996 | 39 | 0.140 |
Why?
| Burnout, Professional | 1 | 2022 | 322 | 0.140 |
Why?
| Homocysteine | 1 | 1997 | 136 | 0.140 |
Why?
| Subclavian Artery | 1 | 1997 | 29 | 0.140 |
Why?
| Vascular Diseases | 2 | 2015 | 230 | 0.140 |
Why?
| Tertiary Care Centers | 1 | 2017 | 126 | 0.140 |
Why?
| Cardiovascular Diseases | 4 | 2021 | 1727 | 0.130 |
Why?
| Incidental Findings | 1 | 2016 | 70 | 0.130 |
Why?
| Curriculum | 4 | 2024 | 819 | 0.130 |
Why?
| Sepsis | 2 | 2016 | 509 | 0.130 |
Why?
| Endarterectomy, Carotid | 2 | 2013 | 42 | 0.130 |
Why?
| Vascular Malformations | 1 | 2016 | 47 | 0.130 |
Why?
| Survival Rate | 4 | 2021 | 1644 | 0.130 |
Why?
| Hypertension | 2 | 2001 | 1056 | 0.120 |
Why?
| Osteotomy | 1 | 2016 | 146 | 0.120 |
Why?
| Interprofessional Relations | 1 | 2017 | 249 | 0.120 |
Why?
| Disease Progression | 3 | 2014 | 2380 | 0.120 |
Why?
| Kaplan-Meier Estimate | 4 | 2021 | 811 | 0.120 |
Why?
| Popliteal Vein | 1 | 1994 | 4 | 0.120 |
Why?
| Attitude of Health Personnel | 2 | 2021 | 975 | 0.120 |
Why?
| Multidetector Computed Tomography | 1 | 2014 | 26 | 0.120 |
Why?
| Multiple Trauma | 1 | 2014 | 96 | 0.110 |
Why?
| Endarterectomy | 1 | 1993 | 6 | 0.110 |
Why?
| Recurrence | 4 | 2014 | 935 | 0.110 |
Why?
| Thoracotomy | 1 | 2014 | 75 | 0.110 |
Why?
| Premedication | 1 | 1993 | 36 | 0.110 |
Why?
| Surgery, Computer-Assisted | 1 | 2014 | 62 | 0.110 |
Why?
| Bandages | 1 | 1993 | 31 | 0.110 |
Why?
| Analgesics, Opioid | 1 | 2020 | 771 | 0.110 |
Why?
| Recovery of Function | 3 | 2011 | 574 | 0.110 |
Why?
| Program Evaluation | 1 | 2017 | 822 | 0.110 |
Why?
| Research Design | 2 | 2009 | 928 | 0.110 |
Why?
| Ulnar Artery | 1 | 1992 | 2 | 0.100 |
Why?
| Injury Severity Score | 3 | 2021 | 499 | 0.100 |
Why?
| Ischemic Attack, Transient | 1 | 1993 | 62 | 0.100 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 1183 | 0.100 |
Why?
| Stress, Psychological | 1 | 2020 | 944 | 0.100 |
Why?
| Young Adult | 6 | 2021 | 10471 | 0.100 |
Why?
| Predictive Value of Tests | 4 | 2021 | 1796 | 0.100 |
Why?
| Life Tables | 3 | 1998 | 17 | 0.100 |
Why?
| Seasons | 1 | 2014 | 442 | 0.100 |
Why?
| Renal Insufficiency | 1 | 2014 | 137 | 0.100 |
Why?
| Prognosis | 5 | 2021 | 3329 | 0.100 |
Why?
| Radial Artery | 1 | 1992 | 66 | 0.100 |
Why?
| Fingers | 1 | 1992 | 83 | 0.100 |
Why?
| Research Personnel | 1 | 2013 | 149 | 0.100 |
Why?
| Thrombectomy | 2 | 2003 | 51 | 0.100 |
Why?
| Aorta, Thoracic | 1 | 2014 | 256 | 0.100 |
Why?
| Oregon | 1 | 2011 | 66 | 0.090 |
Why?
| Hypoglycemic Agents | 1 | 2019 | 1013 | 0.090 |
Why?
| Adolescent | 7 | 2023 | 17853 | 0.090 |
Why?
| Fellowships and Scholarships | 1 | 2013 | 227 | 0.090 |
Why?
| Efficiency | 1 | 2011 | 84 | 0.090 |
Why?
| Reproducibility of Results | 3 | 2021 | 2765 | 0.090 |
Why?
| Arteries | 2 | 2022 | 247 | 0.090 |
Why?
| Catheterization | 2 | 2003 | 159 | 0.090 |
Why?
| Workload | 1 | 2011 | 132 | 0.090 |
Why?
| Controlled Clinical Trials as Topic | 1 | 2009 | 27 | 0.080 |
Why?
| Device Approval | 1 | 2009 | 21 | 0.080 |
Why?
| Skin | 1 | 1993 | 655 | 0.080 |
Why?
| Safety | 1 | 2011 | 298 | 0.080 |
Why?
| Disability Evaluation | 1 | 2011 | 271 | 0.080 |
Why?
| Coated Materials, Biocompatible | 2 | 2023 | 54 | 0.080 |
Why?
| Global Health | 2 | 2021 | 287 | 0.080 |
Why?
| Axillary Vein | 1 | 2008 | 2 | 0.080 |
Why?
| Pregnancy | 1 | 2020 | 5520 | 0.080 |
Why?
| Athletic Injuries | 1 | 2014 | 456 | 0.080 |
Why?
| Colorado | 3 | 2016 | 4099 | 0.080 |
Why?
| Saphenous Vein | 3 | 1998 | 31 | 0.070 |
Why?
| Prevalence | 1 | 2014 | 2251 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 3 | 2021 | 1842 | 0.070 |
Why?
| Radiography | 4 | 2015 | 812 | 0.070 |
Why?
| Practice Guidelines as Topic | 2 | 2011 | 1395 | 0.070 |
Why?
| Biomedical Research | 1 | 2013 | 585 | 0.070 |
Why?
| Family Practice | 2 | 2020 | 427 | 0.070 |
Why?
| Brachial Artery | 1 | 2008 | 176 | 0.070 |
Why?
| Antineoplastic Agents, Phytogenic | 2 | 2021 | 181 | 0.070 |
Why?
| Patient Care Team | 1 | 2011 | 517 | 0.070 |
Why?
| Prospective Studies | 5 | 2021 | 6220 | 0.070 |
Why?
| Iloprost | 1 | 2006 | 46 | 0.060 |
Why?
| Chemotherapy, Adjuvant | 1 | 2007 | 332 | 0.060 |
Why?
| United States Department of Veterans Affairs | 1 | 2009 | 561 | 0.060 |
Why?
| Exercise Test | 3 | 2011 | 544 | 0.060 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2019 | 2096 | 0.060 |
Why?
| Regional Blood Flow | 2 | 1999 | 424 | 0.060 |
Why?
| Carotid Artery, Internal | 2 | 1996 | 36 | 0.060 |
Why?
| Sulfonic Acids | 1 | 2004 | 12 | 0.060 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2020 | 1214 | 0.060 |
Why?
| Single-Blind Method | 2 | 2015 | 258 | 0.060 |
Why?
| Acetates | 1 | 2004 | 95 | 0.060 |
Why?
| Veins | 2 | 1995 | 55 | 0.060 |
Why?
| Blood Pressure | 2 | 2021 | 1538 | 0.060 |
Why?
| Specialty Boards | 1 | 2024 | 32 | 0.060 |
Why?
| Clinical Trials as Topic | 1 | 2008 | 932 | 0.060 |
Why?
| Forecasting | 2 | 2001 | 330 | 0.050 |
Why?
| Thromboplastin | 1 | 2023 | 71 | 0.050 |
Why?
| Atherectomy | 1 | 2023 | 33 | 0.050 |
Why?
| Sexism | 1 | 2023 | 44 | 0.050 |
Why?
| Survival Analysis | 2 | 2004 | 1211 | 0.050 |
Why?
| Physical Exertion | 1 | 2004 | 209 | 0.050 |
Why?
| Mass Screening | 1 | 2009 | 1005 | 0.050 |
Why?
| Societies, Medical | 2 | 2009 | 664 | 0.050 |
Why?
| Psychomotor Performance | 1 | 2004 | 280 | 0.050 |
Why?
| Morbidity | 1 | 2023 | 280 | 0.050 |
Why?
| Numbers Needed To Treat | 1 | 2021 | 8 | 0.050 |
Why?
| Educational Measurement | 1 | 2024 | 243 | 0.050 |
Why?
| Off-Label Use | 1 | 2022 | 51 | 0.050 |
Why?
| Mobility Limitation | 1 | 2022 | 60 | 0.050 |
Why?
| Heart Failure | 1 | 2014 | 1945 | 0.050 |
Why?
| Hemangioendothelioma, Epithelioid | 1 | 2001 | 5 | 0.050 |
Why?
| Oxygen Consumption | 1 | 2004 | 588 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2004 | 750 | 0.050 |
Why?
| Vascular Neoplasms | 1 | 2001 | 15 | 0.050 |
Why?
| Cadaver | 1 | 2022 | 299 | 0.050 |
Why?
| Artificial Limbs | 1 | 2003 | 116 | 0.050 |
Why?
| Angioplasty | 1 | 2001 | 40 | 0.050 |
Why?
| Habits | 1 | 2020 | 36 | 0.050 |
Why?
| Tetrazoles | 1 | 2001 | 32 | 0.050 |
Why?
| Empathy | 1 | 2022 | 139 | 0.050 |
Why?
| Aneurysm, False | 1 | 2001 | 45 | 0.050 |
Why?
| Stents | 2 | 2022 | 475 | 0.050 |
Why?
| Severity of Illness Index | 2 | 2008 | 2540 | 0.040 |
Why?
| Equipment Failure | 1 | 2001 | 106 | 0.040 |
Why?
| Arterial Pressure | 1 | 2021 | 99 | 0.040 |
Why?
| Physician's Role | 1 | 2002 | 197 | 0.040 |
Why?
| Joint Dislocations | 1 | 2021 | 57 | 0.040 |
Why?
| Tissue Plasminogen Activator | 1 | 2022 | 225 | 0.040 |
Why?
| Angiography | 1 | 2001 | 174 | 0.040 |
Why?
| Radiography, Interventional | 1 | 2001 | 104 | 0.040 |
Why?
| Prosthesis Design | 1 | 2022 | 285 | 0.040 |
Why?
| Diagnostic Imaging | 3 | 2007 | 275 | 0.040 |
Why?
| Internal Medicine | 1 | 2002 | 211 | 0.040 |
Why?
| Internationality | 1 | 2020 | 143 | 0.040 |
Why?
| Knee Injuries | 1 | 2021 | 89 | 0.040 |
Why?
| Pulse | 1 | 1999 | 27 | 0.040 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2001 | 179 | 0.040 |
Why?
| Toe Joint | 1 | 1999 | 11 | 0.040 |
Why?
| Proprotein Convertase 9 | 1 | 2020 | 61 | 0.040 |
Why?
| Pulsatile Flow | 1 | 1999 | 54 | 0.040 |
Why?
| Debridement | 1 | 1999 | 73 | 0.040 |
Why?
| Pain, Postoperative | 1 | 2020 | 191 | 0.040 |
Why?
| Metatarsal Bones | 1 | 1999 | 46 | 0.040 |
Why?
| Myocardial Revascularization | 1 | 2019 | 67 | 0.040 |
Why?
| Arteriovenous Fistula | 1 | 1998 | 29 | 0.040 |
Why?
| Catheters, Indwelling | 1 | 1998 | 79 | 0.040 |
Why?
| Postoperative Care | 1 | 2019 | 222 | 0.040 |
Why?
| Knee Joint | 1 | 2021 | 323 | 0.040 |
Why?
| Antiviral Agents | 1 | 2023 | 645 | 0.040 |
Why?
| Intraoperative Complications | 1 | 1998 | 122 | 0.040 |
Why?
| Carotid Arteries | 1 | 2019 | 180 | 0.040 |
Why?
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 62 | 0.040 |
Why?
| Coronary Disease | 1 | 2000 | 348 | 0.040 |
Why?
| Age Factors | 1 | 2004 | 2894 | 0.040 |
Why?
| Diagnosis, Differential | 2 | 2014 | 1342 | 0.040 |
Why?
| Combined Modality Therapy | 1 | 2020 | 1121 | 0.030 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2001 | 373 | 0.030 |
Why?
| Neck | 1 | 1997 | 85 | 0.030 |
Why?
| Administration, Oral | 1 | 2019 | 728 | 0.030 |
Why?
| Health Promotion | 1 | 2022 | 686 | 0.030 |
Why?
| Blood Loss, Surgical | 1 | 2016 | 84 | 0.030 |
Why?
| Cardiology | 1 | 2019 | 259 | 0.030 |
Why?
| Risk | 1 | 2019 | 812 | 0.030 |
Why?
| Postoperative Hemorrhage | 1 | 2016 | 74 | 0.030 |
Why?
| Fractures, Bone | 1 | 2021 | 367 | 0.030 |
Why?
| Risk Management | 2 | 2007 | 89 | 0.030 |
Why?
| Foot | 1 | 1996 | 103 | 0.030 |
Why?
| Pain Measurement | 2 | 2009 | 444 | 0.030 |
Why?
| Aortic Rupture | 1 | 1995 | 25 | 0.030 |
Why?
| Aorta, Abdominal | 1 | 1995 | 39 | 0.030 |
Why?
| Vaccination | 1 | 2023 | 1204 | 0.030 |
Why?
| Groin | 1 | 1994 | 13 | 0.030 |
Why?
| Exercise | 1 | 2004 | 1644 | 0.030 |
Why?
| Tomography, X-Ray Computed | 2 | 2016 | 2286 | 0.030 |
Why?
| Glasgow Coma Scale | 1 | 2014 | 153 | 0.030 |
Why?
| Carotid Artery, External | 1 | 1993 | 3 | 0.030 |
Why?
| Orthopedic Equipment | 1 | 1993 | 5 | 0.030 |
Why?
| Operative Time | 1 | 2014 | 106 | 0.030 |
Why?
| Venous Insufficiency | 1 | 1993 | 11 | 0.030 |
Why?
| Longitudinal Studies | 2 | 1999 | 2387 | 0.030 |
Why?
| Cerebral Revascularization | 1 | 1993 | 15 | 0.030 |
Why?
| Prosthesis Failure | 1 | 1994 | 115 | 0.030 |
Why?
| Carotid Artery, Common | 1 | 1993 | 29 | 0.030 |
Why?
| Cerebral Angiography | 1 | 1993 | 109 | 0.030 |
Why?
| Surgical Wound Infection | 1 | 2016 | 248 | 0.030 |
Why?
| Ankle | 1 | 1993 | 70 | 0.030 |
Why?
| Arteritis | 1 | 1993 | 27 | 0.030 |
Why?
| Inflammation | 1 | 2023 | 2480 | 0.030 |
Why?
| Pressure | 1 | 1993 | 214 | 0.030 |
Why?
| Housing | 1 | 1993 | 114 | 0.030 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 1177 | 0.030 |
Why?
| Cohort Studies | 1 | 2022 | 4895 | 0.030 |
Why?
| Nursing Homes | 1 | 1993 | 138 | 0.020 |
Why?
| Lung | 1 | 2004 | 3561 | 0.020 |
Why?
| Pain | 2 | 2009 | 705 | 0.020 |
Why?
| Child | 2 | 2020 | 18420 | 0.020 |
Why?
| Sickness Impact Profile | 1 | 2011 | 50 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2021 | 4410 | 0.020 |
Why?
| Hospitalization | 1 | 1999 | 1752 | 0.020 |
Why?
| Pneumonia | 1 | 2016 | 568 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 1999 | 1481 | 0.020 |
Why?
| Equipment Safety | 1 | 2009 | 39 | 0.020 |
Why?
| Length of Stay | 1 | 2014 | 962 | 0.020 |
Why?
| Ligation | 1 | 2008 | 75 | 0.020 |
Why?
| Illinois | 1 | 2008 | 37 | 0.020 |
Why?
| Tissue and Organ Harvesting | 1 | 2008 | 62 | 0.020 |
Why?
| Smoking | 1 | 2015 | 1383 | 0.020 |
Why?
| Cardiovascular Agents | 1 | 2009 | 126 | 0.020 |
Why?
| Equipment Design | 1 | 2009 | 508 | 0.020 |
Why?
| Magnetic Resonance Angiography | 1 | 2009 | 220 | 0.020 |
Why?
| Constriction, Pathologic | 1 | 2008 | 208 | 0.020 |
Why?
| Ulcer | 1 | 2007 | 28 | 0.020 |
Why?
| Cerebral Arterial Diseases | 1 | 2007 | 42 | 0.020 |
Why?
| Registries | 1 | 2014 | 1768 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2009 | 668 | 0.020 |
Why?
| Drug Carriers | 1 | 2006 | 112 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2006 | 371 | 0.020 |
Why?
| Sterol O-Acyltransferase | 1 | 2004 | 4 | 0.020 |
Why?
| Acetamides | 1 | 2004 | 25 | 0.010 |
Why?
| Hemodynamics | 1 | 2009 | 1012 | 0.010 |
Why?
| Reference Values | 1 | 2006 | 743 | 0.010 |
Why?
| Cost-Benefit Analysis | 1 | 2007 | 544 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2006 | 718 | 0.010 |
Why?
| Hyperemia | 1 | 2004 | 45 | 0.010 |
Why?
| Ultrasonography | 1 | 2006 | 634 | 0.010 |
Why?
| Blood Flow Velocity | 1 | 2004 | 387 | 0.010 |
Why?
| Lipids | 1 | 2006 | 580 | 0.010 |
Why?
| Sulfonamides | 1 | 2004 | 445 | 0.010 |
Why?
| World Health Organization | 1 | 2000 | 102 | 0.010 |
Why?
| Algorithms | 1 | 2007 | 1469 | 0.010 |
Why?
| Costs and Cost Analysis | 1 | 2000 | 196 | 0.010 |
Why?
| Heart Function Tests | 1 | 2000 | 58 | 0.010 |
Why?
| Aneurysm, Ruptured | 1 | 1998 | 34 | 0.010 |
Why?
| Epoprostenol | 1 | 1999 | 133 | 0.010 |
Why?
| Preoperative Care | 1 | 2000 | 319 | 0.010 |
Why?
| Models, Theoretical | 1 | 2000 | 515 | 0.010 |
Why?
| Patient Satisfaction | 1 | 2000 | 578 | 0.010 |
Why?
| Gangrene | 1 | 1996 | 6 | 0.010 |
Why?
| Embolization, Therapeutic | 1 | 1998 | 178 | 0.010 |
Why?
| Ultrasonography, Doppler, Color | 1 | 1995 | 33 | 0.010 |
Why?
| Health Status | 1 | 2000 | 722 | 0.010 |
Why?
| Takayasu Arteritis | 1 | 1993 | 8 | 0.010 |
Why?
| Behcet Syndrome | 1 | 1993 | 16 | 0.010 |
Why?
| Infant, Newborn | 1 | 1999 | 5047 | 0.000 |
Why?
|
|
Nehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|